iCAD (NASDAQ:ICAD) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

Shares of iCAD, Inc. (NASDAQ:ICAD) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.61 and traded as high as $2.06. iCAD shares last traded at $1.96, with a volume of 197,827 shares.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of iCAD from a “sell” rating to a “hold” rating in a report on Thursday, November 21st.

iCAD Price Performance

The firm has a 50 day moving average of $1.83 and a 200-day moving average of $1.61. The stock has a market capitalization of $52.02 million, a P/E ratio of -15.08 and a beta of 1.40.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in iCAD stock. Perritt Capital Management Inc lifted its holdings in shares of iCAD, Inc. (NASDAQ:ICAD) by 14.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 159,900 shares of the technology company’s stock after acquiring an additional 19,917 shares during the period. Perritt Capital Management Inc owned approximately 0.60% of iCAD worth $208,000 as of its most recent filing with the SEC. 24.61% of the stock is currently owned by institutional investors.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.